Concurrent chemotherapy and immunotherapy

Details for Australian Patent Application No. 2006312013 (hide)

Owner Duke University The Board of Regents of The University of Texas System

Inventors Sampson, John H.; Bigner, Darell D.; Mitchell, Duane; Heimberger, Amy

Agent Freehills

Pub. Number AU-B-2006312013

PCT Pub. Number WO2007/056061

Priority 60/732,741 02.11.05 US

Filing date 2 November 2006

Wipo publication date 18 May 2007

Acceptance publication date 4 October 2012

International Classifications

A61K 38/00 Medicinal preparations containing peptides

A61K 38/18 Medicinal preparations containing peptides - Growth factors

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/056061 Priority application(s): WO2007/056061

19 June 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name University of Texas M.DAnderson Cancer Center, Application No. 2006312013, under INID (71) correct the name to read University of Texas M.D.Anderson Cancer Center.

11 September 2008 Alteration of Name

  The name of the applicant has been altered to The Board of Regents of The University of Texas System; Duke University

4 October 2012 Application Accepted

  Published as AU-B-2006312013

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006312014-Methods for adapting mammalian cells

2006312012-Security system